Market Cap | ₹16,961Cr |
ROE | 8.92% |
P/E Ratio(TTM) | 36.85 |
EPS(TTM) | 28.89 |
P/B Ratio | 2.71 |
Dividend Yield | 0.47% |
Industry P/E | 34.72 |
Book Value | 392.66 |
Debt to Equity | 0.44 |
Face Value | 1 |
Parent Organisation | Jubilant Pharmova Limited |
Managing Director | Mr. Arjun Bhartia |
NSE Symbol | JUBLPHARMA |
FUND NAME | AUM(%) |
---|---|
Bandhan Focused Fund Direct Growth | 2.87% |
Kotak Contra Fund Direct Growth | 1.44% |
Bandhan Small Cap Fund Direct Growth | 1.21% |
Quant Small Cap Fund Direct Plan Growth | 1.19% |
COMPANY | 52 WEEK | MARKET PRICE | P/E Ratio | |
---|---|---|---|---|
Divi's Laboratories | NA (0.00%) | 70.63 | ||
Neuland Laboratories | NA (0.00%) | 106.39 | ||
Acutaas Chemicals | NA (0.00%) | 61.73 | ||
Aarti Drugs | NA (0.00%) | 23.09 |